Evaluation of risks when choosing directions for research as scientific-technological priorities on the basis of genome-wide sequencing

L. A. Tsvetkova (), F. A. Kurakov () and O. V. Cherchenko ()

Economics of Science, 2015, vol. 1, issue 3

Abstract: Using genome-sequencing as an example there are analysed risks when choosing priorities for science and technologies development in Russia, based only on the analysis of trends in development of global biomedicine, but not factoring resource provision of the direction. It is demonstrated that in today's Russia there is a lack of sufficient numbers of competent doctors-genetics. The volume of core courses in medical universities (36 hours) in Russian Federation is inadequate to the intensity of the development of this direction and growth in numbers of genetic diseases. Modern domestic park of sequenators is represented by the equipment of early generation, using which prevents it to meet the world standards of research in the area of genome medicine. In practice the technology of genome sequencing is not widely used in the health care due to high costs of the diagnostics procedures. There is a conclusion drawn about unviability of choice as a priority direction of development, which doesn't have the personnel and instrumental provision as well as demand in the real sector of economy.

Date: 2015
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://ecna.elpub.ru/jour/article/viewFile/25/22 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abz:journl:y:2015:id:25

Access Statistics for this article

More articles in Economics of Science from Delo Publishing house
Bibliographic data for series maintained by Кочетков Дмитрий Михайлович ().